Las Vegas: Are Frontotemporal Dementia Models Fit for Pharma?
in terms of recapitulating FTD phenotype,” Boxer told ARF.—Esther Landhuis. This is Part 2 of a three-part
ALL NEWS
378 RESULTS
You searched Esther
Sort By:
- Most Recent
- Most Commented
- Most Relevant
San Francisco: Tau—Time to Shine as Therapeutic Target?
the drill will penetrate the topic of synaptic pathophysiology in neurodegenerative disease.—Esther
Wave of New BACE Inhibitors Heading to Phase 2
forward with these compounds in clinical trials.”—Esther Landhuis. None